In our study, the expression of CD169 and CD163 was also significantly higher in M-CSF MDMs in comparison with GM-CSF MDMs, stressing the relevance of considering M-CSF MDMs as the most adapted in vitro macrophage model for SSc. This evidence concerns the gene SIGLEC1 and systemic sclerosis.